#23 Matthew Johnson: The Forefront of Psilocybin, Ecstasy, and Psychedelics as Treatment for Addiction

1:40:30
 
Partager
 

Manage episode 299520598 series 2855068
Par Dan Cleland, découvert par Player FM et notre communauté - Le copyright est détenu par l'éditeur, non par Player F, et l'audio est diffusé directement depuis ses serveurs. Appuyiez sur le bouton S'Abonner pour suivre les mises à jour sur Player FM, ou collez l'URL du flux dans d'autre applications de podcasts.

On episode 23 of Business, Life, and Ayahuasca, we are pleased to have a guest that is at the forefront of psychedelic research, Dr. Matthew Johnson. Dr. Matthew Johnson is a professor of psychiatry and behavioral sciences at Johns Hopkins University. In 2014 he developed and published the first research on psychedelic treatment of tobacco addiction. Furthermore Dr. Johnson and colleagues published the largest study of psilocybin in treating cancer distress in 2016. Dr. Matthew Johnson expands upon these topics and many more in this episode of Business, Life, and Ayahuasca. As always, this episode is brought to you by Soltara Healing Center.

Connect with Matthew Johnson

Website- https://www.hopkinsmedicine.org/profiles/details/matthew-johnson

Twitter- @Drug_Researcher

Connect with Daniel Cleland

Website - http://danielcleland.com/

Instagram - @danielccleland

Facebook - @danielccleland

Sign up for my Newsletter: http://danielcleland.com/

Subscribe to my YouTube channel: https://www.youtube.com/c/DanielCleland

Subscribe to the podcast:

iTunes

Spotify

Google

27 episodes